Literature DB >> 20634456

Public health surveillance for methicillin-resistant Staphylococcus aureus: comparison of methods for classifying health care- and community-associated infections.

Dawn M Sievert1, Mark L Wilson, Melinda J Wilkins, Brenda W Gillespie, Matthew L Boulton.   

Abstract

OBJECTIVES: We compared 3 methods for classifying methicillin-resistant Staphylococcus aureus (MRSA) infections as health care associated or community associated for use in public health surveillance.
METHODS: We analyzed data on MRSA infections reported to the Michigan Department of Community Health from October 1, 2004, to December 31, 2005. Patient demographics, risk factors, infection information, and susceptibility were collected for 2151 cases. We classified each case by the health care risk factor, infection-type, and susceptibility pattern methods and compared the results of the 3 methods.
RESULTS: Demographic, clinical, and microbiological variables yielded similar health care-associated and community-associated distributions when classified by risk factor and infection type. When 2 methods yielded the same classifications, the overall distribution was similar to classification by 3 methods. No specific combination of 2 methods was superior.
CONCLUSIONS: MRSA categorization by 2 methods is more accurate than it is by a single method. The health care risk factor and infection-type methods yield comparable classification results. Accuracy is increased by using more variables; however, further research is needed to identify the optimal combination.

Entities:  

Mesh:

Year:  2010        PMID: 20634456      PMCID: PMC2920987          DOI: 10.2105/AJPH.2009.181958

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  40 in total

1.  Methicillin-resistant Staphylococcus aureus infections in correctional facilities---Georgia, California, and Texas, 2001-2003.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2003-10-17       Impact factor: 17.586

2.  Comparative molecular analysis of community- or hospital-acquired methicillin-resistant Staphylococcus aureus.

Authors:  P D Fey; B Saïd-Salim; M E Rupp; S H Hinrichs; D J Boxrud; C C Davis; B N Kreiswirth; P M Schlievert
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

3.  Methicillin-resistant Staphylococcus aureus skin or soft tissue infections in a state prison--Mississippi, 2000.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2001-10-26       Impact factor: 17.586

4.  Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996-1998.

Authors:  T S Naimi; K H LeDell; D J Boxrud; A V Groom; C D Steward; S K Johnson; J M Besser; C O'Boyle; R N Danila; J E Cheek; M T Osterholm; K A Moore; K E Smith
Journal:  Clin Infect Dis       Date:  2001-09-05       Impact factor: 9.079

5.  Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection.

Authors:  Timothy S Naimi; Kathleen H LeDell; Kathryn Como-Sabetti; Stephanie M Borchardt; David J Boxrud; Jerome Etienne; Susan K Johnson; Francois Vandenesch; Scott Fridkin; Carol O'Boyle; Richard N Danila; Ruth Lynfield
Journal:  JAMA       Date:  2003-12-10       Impact factor: 56.272

6.  Methicillin-resistant staphylococcus aureus infections among competitive sports participants--Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000-2003.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2003-08-22       Impact factor: 17.586

7.  Widespread skin and soft-tissue infections due to two methicillin-resistant Staphylococcus aureus strains harboring the genes for Panton-Valentine leucocidin.

Authors:  Binh An Diep; George F Sensabaugh; Naraporn Somboonna; Naraporn S Somboona; Heather A Carleton; Françoise Perdreau-Remington
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

8.  Injecting drug use and community-associated methicillin-resistant Staphylococcus aureus infection.

Authors:  Hsin Huang; Stuart H Cohen; Jeff H King; Caroline Monchaud; Hien Nguyen; Neil M Flynn
Journal:  Diagn Microbiol Infect Dis       Date:  2008-02-21       Impact factor: 2.803

9.  Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database.

Authors:  Linda K McDougal; Christine D Steward; George E Killgore; Jasmine M Chaitram; Sigrid K McAllister; Fred C Tenover
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

Review 10.  Treatment of community-acquired methicillin-resistant Staphylococcus aureus in children.

Authors:  John F Marcinak; Arthur L Frank
Journal:  Curr Opin Infect Dis       Date:  2003-06       Impact factor: 4.915

View more
  4 in total

1.  Pharmacokinetic-pharmacodynamic evaluation of daptomycin, tigecycline, and linezolid versus vancomycin for the treatment of MRSA infections in four western European countries.

Authors:  A Canut; A Isla; C Betriu; A R Gascón
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-02-28       Impact factor: 3.267

2.  Fosfomycin plus β-Lactams as Synergistic Bactericidal Combinations for Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureus.

Authors:  A del Río; C García-de-la-Mària; J M Entenza; O Gasch; Y Armero; D Soy; C A Mestres; J M Pericás; C Falces; S Ninot; M Almela; C Cervera; J M Gatell; A Moreno; P Moreillon; F Marco; J M Miró
Journal:  Antimicrob Agents Chemother       Date:  2015-11-02       Impact factor: 5.191

3.  Incidence of Community-associated Methicillin-resistant Staphylococcus aureus Infections in a Regional Hospital.

Authors:  Hidenobu Kawabata; Manabu Murakami; Kengo Kisa; Masaji Maezawa
Journal:  J Rural Med       Date:  2011

4.  Methicillin-resistant and methicillin-susceptible community-acquired Staphylococcus aureus infection among children.

Authors:  Renata Tavares Gomes; Ticiana Goyanna Lyra; Noraney Nunes Alves; Renilza Menezes Caldas; Maria-Goreth Barberino; Cristiana Maria Nascimento-Carvalho
Journal:  Braz J Infect Dis       Date:  2013-09-19       Impact factor: 3.257

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.